Lucy felt invisible when she was diagnosed—as if people looked at her as a lost cause.
Cape Elizabeth, ME (PRWEB) October 07, 2014
The Cape Elizabeth community is coming together for a 5k family fun run/walk on October 18, 2014 to benefit The Lucy Fund, an official donor-designated fund of the National Foundation for Cancer Research that raises money specifically for metastatic cancer research.
The fund is named for Lucy Elicker Stanovick, who was diagnosed in 2008 at age 42 with metastatic breast cancer—breast cancer that then spread to other areas of her body. Rather than merely accepting her fate, Lucy took a stand and raised more than $200,000 towards the goal of making metastatic breast cancer a chronic, rather than deadly, disease.
“Lucy felt invisible when she was diagnosed—as if people looked at her as a lost cause,” said Beth Elicker, Lucy’s sister and organizer of the October 18 5k. “But she continued to live her life with vibrancy and intent right up until she passed last August. Through Lucy's efforts and the impact she has made, I am reminded how, collectively, we truly can make a difference. She was a very special person and is missed dearly.”
The Lucy Fund 5k will begin at Fort William Park at 9:00 a.m. on October 18, 2014. Participants can register online until October 16, 2014. The race will be timed, and winners will be awarded in several age categories.
The cost to participate is $25 prior to the event and $30 on race day. All money raised will be donated to The Lucy Fund. For more information on The Lucy Fund, please visit http://www.nfcr.org/lucyfund.
For more information on the race or to register, please visit http://www.running4free.com/RaceDetails.aspx?raceid=252 or contact Beth Elicker at 207-233-0022.
About the National Foundation for Cancer Research
The National Foundation for Cancer Research (NFCR) is a leading cancer research charity dedicated to funding cancer research and public education relating to cancer prevention, earlier diagnosis, better treatments and, ultimately, a cure for cancer. NFCR promotes and facilitates collaboration among scientists to accelerate the pace of discovery from bench to bedside.
Since 1973, NFCR has provided over $320 million in support of discovery-oriented cancer research focused on understanding how and why cells become cancerous, and on public education relating to cancer prevention, detection, and treatment. NFCR scientists are discovering cancer's molecular mysteries and translating these discoveries into therapies that hold the hope for curing cancer. NFCR is about Research for a Cure - cures for all types of cancer. For more information, please visit http://www.NFCR.org.